Monday 10th November 2025 15:00 - 16:00 (GMT)
In this focused 60-minute masterclass, Professor James Robinson, expert in Health Economics at the University of California, Berkeley, examines how Donald Trump’s return to office is reshaping the pharmaceutical landscape in the United States and beyond.
The masterclass will explore the return of the Most Favored Nation pricing policy, examining its implications for US drug pricing and international reference systems. It will also consider the effects of ongoing research funding cuts and workforce reductions at major institutions such as the National Institutes for Health (NIH) and the Food and Drug Administration (FDA).
Looking at the growing drive to reshore pharmaceutical manufacturing, with tariffs and investment incentives aimed at encouraging foreign firms to build in the United States.
James will offer clear, practical insight into how these shifts affect Life Sciences innovation, global pricing dynamics and commercial strategy for Life Sciences companies operating in or with the US market.

10th Nov 2025 15:00 – 16:00 (GMT)
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now